Vorsitz: T. Münzel (Mainz), D. Zohlnhöfer-Momm (Berlin)
| (V318) | Effects of protein A immunoadsorption on methylglyoxal levels in patients with chronic dilated cardiomyopathy and diabetes mellitus |
| A. Dösch, S. Müller, S. Celik, L. Frankenstein, P. Ehlermann, C. Zugck, H. A. Katus (Heidelberg) | |
| (V319) | Effects of a dual endothelin receptor antagonist (Bosentan®) on Hemodynamics and Clinical Outcome in Heart Failure Patients with Pulmonary Hypertension Awaiting Cardiac Transplantation |
| U. Schulz, T. K. Hefke, U. Fuchs, S. Schulte-Eistrup, B. Schulze, A. Zittermann, J. Gummert (Bad Oeynhausen) | |
| (V320) | Intrakoronare Progenitorzelltherapie und Arrhythmie-Risiko bei Patienten mit chronischer Herzinsuffizienz |
| S. Palm, D. Leistner, J. Schmitt, J. Klotsche, S. Estel, A. Fink, C. W. Israel, B. Aßmus, G.-Z. Duray, S. Dimmeler, S. Hohnloser, A. M. Zeiher (Frankfurt am Main, Bad Nauheim, Dresden, Bielefeld) | |
| (V321) | Hemodynamic improvements of a novel dual acting V1a/V2 vasopressin receptor antagonist: Comparison with selective V2 receptor blockade |
| P. Kolkhof, T. Mondritzki, H. Trübel, M. Delbeck, E. Perzborn, E. Pook, C. Schmeck, C. Fürstner, B. Albrecht-Küpper (Wuppertal) | |
| (V322) | First baseline results from Aldo-DHF, the largest prospective international multicenter trial on diastolic heart failure |
| E. Kraigher-Krainer, A. Duvinage, R. Wachter, G. Gelbrich, A. Schmidt, W. Kamke, H.-D. Düngen, M. Halle, B. Pieske, F. Edelmann (Graz, AT; Göttingen, Leipzig, Burg (Spreewald), Berlin, München) | |
| (V323) | A Decade of Developments in Heart Failure Treatment: A Comparison of Therapy and Outcome in a Secondary and Tertiary Hospital Setting |
| J. Franke, C. Zugck, M. Hochadel, J. S. Wolter, L. Frankenstein, R. Winkler, P. Ehlermann, M. Nelles, R. Zahn, H. A. Katus, J. Senges (Heidelberg, Ludwigshafen) |